Variant · Snv
FBXW7 R465H
CI-VAR-00003859Explore in graph →CIViC 2647
Curated evidence
Evidence by cancer (2 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 17646409
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| T Acute Lymphoblastic Leukemia1 | ||||||||
| FBXW7 R465H | (predisposing) | Predisposing | D | Supports Predisposition | 4 | submitted | EID7174In mouse models, constitutive NOTCH signaling contributes to the genesis of breast cancer, medulloblastoma, and T cell leukemia, whereas in human cancer its role is best exemplified by T cell acute ly… (full text at CIViC) PMID 17646409 · O'Neil et al., 2007 · Open in CIViC | civic |
| Unmapped disease1unmapped disease | ||||||||
| FBXW7 R465H | (functional) | Functional | E | Supports Loss Of Function | 3 | rejected | EID7170T-ALL mutations in FBXW7 are predominantly located at arginine residues R479Q, R505C, and R465H and result in FBXW7 mutants unable to bind to or degrade targets The R465H variant led to low levels of … (full text at CIViC) | |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available